Promed DOA-10 Multi-Drug Abuse Rapid Test Kit – 10 Panel

The Promed DOA-10 Rapid Test Kit is a multi-panel diagnostic screening kit intended for the simultaneous qualitative detection of ten drugs of abuse or their metabolites. The test is designed to support preliminary drug screening in hospitals, diagnostic laboratories, rehabilitation centres, occupational health facilities and other professional testing environments. Multi-drug rapid screening tests commonly use competitive lateral flow immunochromatographic technology to identify selected drug metabolites in urine through visible test and control lines. The DOA-10 format enables screening for ten drug categories using a single testing device, reducing the need to perform multiple individual rapid tests. The Promed DOA-10 Rapid Test Kit is suitable for healthcare professionals seeking a convenient solution for preliminary toxicology and substance-use screening. Note: The description reflects the standard DOA-10 testing format. The exact specimen requirements, detection panel and performance characteristics of this Promed version must be confirmed against its package insert before publication. Key Features - 10-panel screening: Designed to screen for ten drug categories or their metabolites. - Rapid testing: Provides preliminary screening results without lengthy laboratory procedures. - Multi-drug assessment: Supports the assessment of several substances from one specimen. - Simple operation: Intended for straightforward professional testing. - Visual interpretation: Uses control and test indicators in typical lateral-flow formats. - No specialized analyzer: Standard DOA-10 lateral-flow devices do not require an electronic reader. - Single-use device: Designed for disposable diagnostic applications. - Compact packaging: Convenient for hospitals, laboratories and occupational health services. - Preliminary toxicology screening: Useful in clinical and appropriately authorized drug-testing programmes.